Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions.
Each year, approximately 22,000 women are diagnosed with ovarian cancer in the United States and about 15,000 American women die from the disease. These numbers are underscored by the sobering fact that currently there is no reliable screening test for the early detection of ovarian cancer. The majority of cases (81%) are not diagnosed until the disease is advanced, at which time a woman's survival is significantly compromised. A woman's lifetime risk of developing ovarian cancer is 1 in 71 and the risk of dying from this disease is 1 in 95. OVARIAN CANCER BRIGADE has raised over $620K that has gone to The Dr. Ursula Matulonis Ovarian Cancer Research Fund at Dana Farber Cancer Institute. Dr. Matulonis is dedicated to research, early detection, quality of life and ultimately and ideally-- a cure for ovarian cancer which if caught early enough is a highly treatable disease.
Thank you for supporting Dana-Farber Cancer Institute and the Jimmy Fund's mission to conquer cancer.